Novartis announced FDA approval for Fabhalta

Go back to Novartis announced FDA approval for Fabhalta
NOVARTIS AG (NYSE: NVS) Delayed: 137.48 --0 (-0%)
Previous Close $137.48    52 Week High $89.15 
Open $137.48    52 Week Low $69.84 
Day High $137.48    P/E N/A 
Day Low $137.48    EPS $0.00 
Volume 46,580